NOVARTIS INDIA Financial Statement Analysis
|
||
The Revenues of NOVARTIS INDIA have decreased by -5.28% YoY .
The Earnings Per Share (EPS) of NOVARTIS INDIA has increased by Positive YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
NOVARTIS INDIA Last 5 Annual Financial Results
[BOM: 500672|NSE : NOVARTIND]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹379 Cr | ₹400 Cr | ₹381 Cr | ₹438 Cr | ₹491 Cr |
Expenses | ₹314 Cr | ₹373 Cr | ₹356 Cr | ₹427 Cr | ₹479 Cr |
Operating Profit (Excl OI) | ₹65 Cr | ₹27 Cr | ₹26 Cr | ₹12 Cr | ₹12 Cr |
Other Income | ₹58 Cr | ₹34 Cr | ₹34 Cr | ₹36 Cr | ₹78 Cr |
Interest | ₹1.75 Cr | ₹4.83 Cr | ₹7.68 Cr | ₹6.39 Cr | ₹1.59 Cr |
Depreciation | ₹6.06 Cr | ₹9.65 Cr | ₹12 Cr | ₹13 Cr | ₹3.18 Cr |
Profit Before Tax | ₹115 Cr | ₹-3.82 Cr | ₹40 Cr | ₹29 Cr | ₹86 Cr |
Profit After Tax | ₹103 Cr | ₹-3.72 Cr | ₹21 Cr | ₹10 Cr | ₹52 Cr |
Consolidated Net Profit | ₹103 Cr | ₹-3.72 Cr | ₹21 Cr | ₹10 Cr | ₹52 Cr |
Earnings Per Share (Rs) | ₹41.88 | ₹-1.51 | ₹8.47 | ₹4.08 | ₹20.98 |
PAT Margin (%) | 22.48 | -0.76 | 4.61 | 1.89 | 8.78 |
ROE(%) | 14.07 | -0.53 | 2.91 | 1.36 | 6.89 |
ROCE(%) | 15.96 | 0.14 | 6.67 | 4.73 | 11.70 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 2,497.0 Cr |
Revenue (TTM) | : | ₹ 330.0 Cr |
Net Profit(TTM) | : | ₹ 95.5 Cr |
EPS (TTM) | : | ₹ 38.7 |
P/E (TTM) | : | 26.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
NOVARTIS INDIA | 3.9% | 2.7% | 80.7% |
ADANI ENTERPRISES | 1.8% | -4.9% | 70.2% |
REDINGTON | 2.5% | -1.3% | 27% |
HONASA CONSUMER | NA | NA | NA |
MMTC | 1.5% | -21.7% | 117.1% |
MSTC | 1.9% | -10.7% | 225.8% |
LLOYDS ENTERPRISES | NA | NA | NA |
VERITAS (INDIA) | 8.2% | 40.5% | 537.8% |
OPTIEMUS INFRACOM | -1.7% | -11.2% | 19.2% |
NOVARTIS INDIA Revenues
[BOM: 500672|NSE : NOVARTIND]
Y-o-Y | -5.28 % |
5 Yr CAGR | -6.27 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹379 Cr | -5.28 | |
Mar2022 | ₹400 Cr | 4.86 | |
Mar2021 | ₹381 Cr | -12.98 | |
Mar2020 | ₹438 Cr | -10.69 | |
Mar2019 | ₹491 Cr | - |
NOVARTIS INDIA Operating Profit
[BOM: 500672|NSE : NOVARTIND]
Y-o-Y | 143.29 % |
5 Yr CAGR | 52.16 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹65 Cr | 143.29 | |
Mar2022 | ₹27 Cr | 4.13 | |
Mar2021 | ₹26 Cr | 118.82 | |
Mar2020 | ₹12 Cr | -3.29 | |
Mar2019 | ₹12 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 156.80 % |
5 Yr CAGR | 62.40 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 17.18% | 156.80 | |
Mar2022 | 6.69% | -0.74 | |
Mar2021 | 6.74% | 151.49 | |
Mar2020 | 2.68% | 8.50 | |
Mar2019 | 2.47% | - |
NOVARTIS INDIA Profit After Tax
[BOM: 500672|NSE : NOVARTIND]
Y-o-Y | Positive |
5 Yr CAGR | 18.87 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹103 Cr | Positive | |
Mar2022 | ₹-3.72 Cr | Negative | |
Mar2021 | ₹21 Cr | 107.34 | |
Mar2020 | ₹10 Cr | -80.53 | |
Mar2019 | ₹52 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Positive |
5 Yr CAGR | 26.50 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 22.48 % | Positive | |
Mar2022 | -0.76 % | Negative | |
Mar2021 | 4.61 % | 143.92 | |
Mar2020 | 1.89 % | -78.47 | |
Mar2019 | 8.78 % | - |
NOVARTIS INDIA Earnings Per Share (EPS)
[BOM: 500672|NSE : NOVARTIND]
Y-o-Y | Positive |
5 Yr CAGR | 18.86 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹42 | Positive | |
Mar2022 | ₹-1.51 | Negative | |
Mar2021 | ₹8.47 | 107.60 | |
Mar2020 | ₹4.08 | -80.55 | |
Mar2019 | ₹21 | - |
NOVARTIS INDIA Return on Capital Employed (ROCE)
[BOM: 500672|NSE : NOVARTIND]
Y-o-Y | 11,300.00 % |
5 Yr CAGR | 8.07 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 15.96% | 11,300.00 | |
Mar2022 | 0.14% | -97.90 | |
Mar2021 | 6.67% | 41.01 | |
Mar2020 | 4.73% | -59.57 | |
Mar2019 | 11.7% | - |
NOVARTIS INDIA Share Price vs Sensex
Current Share Price | : | ₹1,011.0 |
Current MarketCap | : | ₹ 2,497.0 Cr |
Updated EOD on | : | Apr 19,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | 3.9% |
2.7% |
80.7% |
SENSEX | -2.6% |
-0% |
21% |
NOVARTIS INDIA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -1.6% | 8.4% | 61.4% |
S&P BSE MIDSMALLCAP | -2.1% | 6.3% | 61.6% |
S&P BSE ALLCAP | -2.5% | 2.7% | 37.3% |
S&P BSE HEALTHCARE | -3.6% | 0.7% | 51.1% |
You may also like the below Video Courses
FAQ about NOVARTIS INDIA Financials
How the annual revenues of NOVARTIS INDIA have changed ?
The Revenues of NOVARTIS INDIA have decreased by -5.28% YoY .
How the Earnings per Share (EPS) of NOVARTIS INDIA have changed?
The Earnings Per Share (EPS) of NOVARTIS INDIA has increased by Positive YoY .
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of MMTC LTD Intrinsic Value of MSTC LTD |
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs